Brainstorm Financial Statements From 2010 to 2026

BCLI Stock  USD 0.56  0.01  1.82%   
Brainstorm Cell's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Brainstorm Cell's valuation are provided below:
Market Capitalization
6.1 M
Earnings Share
(1.42)
We have found one hundred twenty available fundamental signals for Brainstorm Cell Therapeutics, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Brainstorm Cell Therapeutics prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 13.2 M. Enterprise Value is estimated to decrease to about 13.8 M

Brainstorm Cell Total Revenue

1.03 Million

Check Brainstorm Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brainstorm Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 226.4 K, Interest Expense of 65.8 K or Selling General Administrative of 4.4 M, as well as many indicators such as Price To Sales Ratio of 17.14, Dividend Yield of 0.0 or Days Sales Outstanding of 21.66. Brainstorm financial statements analysis is a perfect complement when working with Brainstorm Cell Valuation or Volatility modules.
  
Build AI portfolio with Brainstorm Stock
Check out the analysis of Brainstorm Cell Correlation against competitors.

Brainstorm Cell Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total AssetsM2.1 M10.5 M
Very volatile
Short and Long Term Debt Total786.6 K828 K2.4 M
Very volatile
Total Current Liabilities10.8 M10.3 M6.1 M
Slightly volatile
Cash204.3 K215.1 K4.4 M
Pretty Stable
Non Current Assets Total1.6 M1.7 MM
Slightly volatile
Cash And Short Term Investments204.3 K215.1 K7.5 M
Very volatile
Common Stock Total Equity14.5 K13.8 K10.4 K
Slightly volatile
Common Stock Shares Outstanding6.4 M6.1 M3.3 M
Pretty Stable
Liabilities And Stockholders EquityM2.1 M10.5 M
Very volatile
Non Current Liabilities Total1.3 M710.7 K1.7 M
Slightly volatile
Other Current Assets147.5 K155.2 K524.1 K
Pretty Stable
Other Stockholder Equity264.3 M251.7 M129 M
Slightly volatile
Total Liabilities11.6 M11 M7.1 M
Slightly volatile
Total Current Assets420.6 K442.8 K8.5 M
Very volatile
Short Term Debt875.8 K631.4 K1.2 M
Very volatile
Common Stock16.9 K16.1 K10.8 K
Slightly volatile
Property Plant And Equipment Net1.6 M1.4 M1.9 M
Slightly volatile
Accounts Payable7.3 MM3.9 M
Slightly volatile
Property Plant And Equipment Gross5.1 M4.9 M2.7 M
Slightly volatile
Non Currrent Assets Other24 K25.3 K130.2 K
Very volatile
Net Receivables68.8 K72.5 K582.2 K
Pretty Stable
Other Liabilities266.9 K141.4 K167.7 K
Pretty Stable
Property Plant Equipment6.4 M6.1 M2.9 M
Slightly volatile
Capital Surpluse233 M221.9 M125.7 M
Slightly volatile
Long Term Investments17.1 K18 K32.4 K
Slightly volatile
Non Current Liabilities Other4.4 M4.2 MM
Slightly volatile
Capital Stock13.4 K16.1 K11.9 K
Slightly volatile
Capital Lease Obligations615.6 K648 K2.5 M
Pretty Stable

Brainstorm Cell Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization226.4 K216 K263.6 K
Very volatile
Selling General Administrative4.4 M8.1 M5.3 M
Slightly volatile
Other Operating Expenses10.4 M13.4 M12.6 M
Slightly volatile
Total Operating Expenses10.4 M13.2 M12.5 M
Slightly volatile
Research DevelopmentM5.1 M8.2 M
Pretty Stable
Selling And Marketing Expenses6.6 M12.3 M10 M
Pretty Stable
Interest Income658.1 K626.8 K228.6 K
Slightly volatile
Reconciled Depreciation224.4 K276 K160.4 K
Slightly volatile

Brainstorm Cell Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.6 M1.7 M4.6 M
Pretty Stable
Depreciation226.9 K216 K153.3 K
Slightly volatile
End Period Cash Flow405.3 K426.6 K4.5 M
Pretty Stable
Stock Based Compensation1.1 M862.5 K1.1 M
Pretty Stable
Change To Netincome1.4 M1.9 M1.3 M
Slightly volatile
Issuance Of Capital Stock12.5 M7.2 M7.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Days Sales Outstanding21.6624.3826.6066
Slightly volatile
Average Payables380.1 K581.3 K606.4 K
Very volatile
Capex To Depreciation0.07420.078134.7166
Slightly volatile
Payables Turnover0.05580.04540.0534
Slightly volatile
Cash Per Share0.03850.040530.338
Slightly volatile
Days Payables Outstanding6.9 K8.3 K7.8 K
Slightly volatile
Income Quality0.50.70.7687
Pretty Stable
Intangibles To Total Assets8.0E-48.0E-40.0251
Slightly volatile
Current Ratio0.03670.03862.6788
Slightly volatile
Receivables Turnover10.7812.1313.2384
Slightly volatile
Capex Per Share0.00510.00540.6645
Slightly volatile
Average Receivables53.4 K35.2 K34.4 K
Very volatile
Interest Debt Per Share0.130.141.1115
Very volatile
Debt To Assets0.660.450.3543
Slightly volatile
Operating Cycle21.6624.3826.6066
Slightly volatile
Days Of Payables Outstanding6.9 K8.3 K7.8 K
Slightly volatile
Quick Ratio0.03670.03862.6788
Slightly volatile
Net Income Per E B T0.720.90.9686
Pretty Stable
Cash Ratio0.02280.0241.0632
Slightly volatile
Days Of Sales Outstanding21.6624.3826.6066
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.181.151.0577
Pretty Stable
Debt Ratio0.660.450.3543
Slightly volatile
Gross Profit Margin0.210.160.1473
Very volatile

Brainstorm Cell Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap13.2 M13.9 M89.3 M
Slightly volatile

Brainstorm Fundamental Market Drivers

Brainstorm Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Brainstorm Cell Financial Statements

Investors use fundamental indicators, such as Brainstorm Cell's revenue or net income, to determine how well the company is positioned to perform in the future. Although Brainstorm Cell's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-693.5 K-658.8 K
Total Revenue976.4 KM
Cost Of Revenue276 K289.8 K
Stock Based Compensation To Revenue 0.80  0.83 
Sales General And Administrative To Revenue 7.47  7.84 
Research And Ddevelopement To Revenue 4.68  4.91 
Capex To Revenue(1.16)(1.22)
Revenue Per Share 0.18  0.19 
Ebit Per Revenue(12.40)(11.78)

Currently Active Assets on Macroaxis

When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out the analysis of Brainstorm Cell Correlation against competitors.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.42)
Return On Assets
(4.00)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.